Implantable Atrial Defibrillator. Introduction: The purpose of our study wa
s to evaluate the effect of repeated cardioversion with an implantable atri
al defibrillator on the clinical outcome of patients with atrial fibrillati
on.
Methods and Results: The effects of the implantable atrial defibrillator on
the total duration of atrial fibrillation, number of atrial fibrillation r
ecurrences, and left atrial size were evaluated prospectively in 16 patient
s with atrial fibrillation (13 men and 3 women; mean age 58 +/- 11 Sears).
Seven patients had no cardiovascular disease, 5 patients had hypertension,
3 patients had coronary heart disease, and 1 patient had congenital heart d
isease. Eight patients had paroxysmal atrial fibrillation for a mean durati
on of 80 +/- 61 months, and eight patients had persistent atrial fibrillati
on for a mean duration of 68 +/- 119 months. Except for one patient who rec
eived digoxin throughout the study, all patients received the same Class I
or III antiarrhythmic agent throughout the study. The implantable atrial de
fibrillator successfully converted 50 (93%) of 54 spontaneous episodes of a
trial fibrillation in 12 patients. During the initial 3 months of clinical
follow-up, the atrial defibrillator documented 261 +/- 270 hours of atrial
fibrillation compared with 126 +/- 172 hours (P = 0.01) during the subseque
nt 3 months. The left atrial size decreased from 4.4 +/- 0.7 cm at the time
of atrial defibrillator implantation to 4.1 +/- 0.6 cm (P = 0.02) 6 months
later. The number of atrial fibrillation recurrences did not change. These
findings were observed in the absence of changes in drug therapy. No compl
ications were observed.
Conclusion: Restoration and maintenance of sinus rhythm in patients with at
rial fibrillation by repeated cardioversion,vith an implantable atrial defi
brillator was associated with a reduction in the total arrhythmia duration
and a reduction in left atrial size. These results suggest that maintenance
of sinus rhythm with the atrial defibrillator may reverse the remodeling p
rocess associated with atrial fibrillation.